Cargando…

Long term complications and vision loss in HLA-B27 uveitis

OBJECTIVES: To evaluate the long term complications and vision loss in HLA-B27 uveitis. METHODS: Retrospective review of subjects with HLA-B27 uveitis in a public tertiary centre between January 2008 and 2020. RESULTS: 562 HLA-B27-positive subjects (834 eyes) had mean follow-up of 9.8 years (8173.2...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ani, Haya H., Sims, Joanne L., Niederer, Rachael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219953/
https://www.ncbi.nlm.nih.gov/pubmed/36038721
http://dx.doi.org/10.1038/s41433-022-02216-x
_version_ 1785049118459035648
author Al-Ani, Haya H.
Sims, Joanne L.
Niederer, Rachael L.
author_facet Al-Ani, Haya H.
Sims, Joanne L.
Niederer, Rachael L.
author_sort Al-Ani, Haya H.
collection PubMed
description OBJECTIVES: To evaluate the long term complications and vision loss in HLA-B27 uveitis. METHODS: Retrospective review of subjects with HLA-B27 uveitis in a public tertiary centre between January 2008 and 2020. RESULTS: 562 HLA-B27-positive subjects (834 eyes) had mean follow-up of 9.8 years (8173.2 eye-years). Median visual acuity at ten years was 0.1 logMAR (IQR 0.0–0.1). Complications occurred in 404 eyes (48.4%): posterior synechiae (39.7%), cataract (22.1%), elevated intraocular pressure (15.5%), cystoid macular oedema (6.0%). Permanent moderate vision loss ( ≤ 0.4 logMAR) due to uveitis occurred in 14 eyes (1.7%) and severe vision loss (≤ 1.0 logMAR) in 7 eyes (0.8%). Complications were more common with older age (OR 1.017 p = 0.016), chronic inflammation (OR 5.272 p < 0.001) and intermediate uveitis (OR 5.982 p < 0.001). CONCLUSIONS: Complications are frequent in HLA-B27 uveitis, especially in older subjects, chronic inflammation and intermediate uveitis. Despite this, the majority of subjects maintain good visual prognosis.
format Online
Article
Text
id pubmed-10219953
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102199532023-05-28 Long term complications and vision loss in HLA-B27 uveitis Al-Ani, Haya H. Sims, Joanne L. Niederer, Rachael L. Eye (Lond) Article OBJECTIVES: To evaluate the long term complications and vision loss in HLA-B27 uveitis. METHODS: Retrospective review of subjects with HLA-B27 uveitis in a public tertiary centre between January 2008 and 2020. RESULTS: 562 HLA-B27-positive subjects (834 eyes) had mean follow-up of 9.8 years (8173.2 eye-years). Median visual acuity at ten years was 0.1 logMAR (IQR 0.0–0.1). Complications occurred in 404 eyes (48.4%): posterior synechiae (39.7%), cataract (22.1%), elevated intraocular pressure (15.5%), cystoid macular oedema (6.0%). Permanent moderate vision loss ( ≤ 0.4 logMAR) due to uveitis occurred in 14 eyes (1.7%) and severe vision loss (≤ 1.0 logMAR) in 7 eyes (0.8%). Complications were more common with older age (OR 1.017 p = 0.016), chronic inflammation (OR 5.272 p < 0.001) and intermediate uveitis (OR 5.982 p < 0.001). CONCLUSIONS: Complications are frequent in HLA-B27 uveitis, especially in older subjects, chronic inflammation and intermediate uveitis. Despite this, the majority of subjects maintain good visual prognosis. Nature Publishing Group UK 2022-08-29 2023-06 /pmc/articles/PMC10219953/ /pubmed/36038721 http://dx.doi.org/10.1038/s41433-022-02216-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Al-Ani, Haya H.
Sims, Joanne L.
Niederer, Rachael L.
Long term complications and vision loss in HLA-B27 uveitis
title Long term complications and vision loss in HLA-B27 uveitis
title_full Long term complications and vision loss in HLA-B27 uveitis
title_fullStr Long term complications and vision loss in HLA-B27 uveitis
title_full_unstemmed Long term complications and vision loss in HLA-B27 uveitis
title_short Long term complications and vision loss in HLA-B27 uveitis
title_sort long term complications and vision loss in hla-b27 uveitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219953/
https://www.ncbi.nlm.nih.gov/pubmed/36038721
http://dx.doi.org/10.1038/s41433-022-02216-x
work_keys_str_mv AT alanihayah longtermcomplicationsandvisionlossinhlab27uveitis
AT simsjoannel longtermcomplicationsandvisionlossinhlab27uveitis
AT niedererrachaell longtermcomplicationsandvisionlossinhlab27uveitis